%0 Journal Article
%T Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program
%A Baek-Yeol Ryoo
%A Joon Oh Park
%A Min-Hee Ryu
%A Myoung Kyun Son
%A Seock-Ah Im
%A Sook Ryun Park
%A Su Jin Lee
%A Tae-Yong Kim
%A Yoon-Koo Kang
%J Archive of "Cancer Research and Treatment : Official Journal of Korean Cancer Association".
%D 2017
%R 10.4143/crt.2016.067
%X The aim of this study was to confirm the efficacy and safety of regorafenib for advanced gastrointestinal stromal tumors (GISTs) reported in the GRID phase III trial in Korean patients
%K Regorafenib
%K Gastrointestinal stromal tumors
%K Management access program
%K Failure to imatinib
%K Sunitinib
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398393/